Henry Schein, Inc.

HSIC · NASDAQ · USD

PoliticiansInstitutionalInsiders

Current holders

Politician	Disclosed
Donald Trump R · EXECUTIVE	net −$35K – $35K 2 disclosures · 1 bought / 1 sold · last Aug 26, 2026
Michael T. McCaul R · HOUSE · TX	−$71K – $363K −$57K – $495K today 22 filings · last Jan 9, 2026
Robert Bresnahan R · HOUSE · PA	$1K – $15K $1K – $20K today 1 filing · last Apr 8, 2025
Carlos Curbelo R · HOUSE · FL	$1K – $15K $1K – $20K today 1 filing · last Aug 28, 2018
Ro Khanna D · HOUSE · CA	−$154K – $154K −$199K – $192K today 22 filings · last May 15, 2026
David B. McKinley R · HOUSE · WV	−$49K – $49K −$67K – $68K today 4 filings · last Dec 20, 2018
Lois Frankel D · HOUSE · FL	−$14K – $14K −$18K – $17K today 2 filings · last Aug 7, 2020
Susan M. Collins R · SENATE · ME	−$48K – $15K −$51K – $36K today 3 filings · last Jan 6, 2022
Thomas R. Suozzi D · HOUSE · NY	−$100K – $19K −$161K – $15K today 4 filings · last Apr 17, 2018

Recent transactions

Trades from Feb 26, 2021 – Aug 26, 2026

Politician	Type	Filed after	Amount
Donald Trump R · EXECUTIVE	Buy	43 days Aug 26, 2026 → Oct 8, 2026	≥$15K
Donald Trump R · EXECUTIVE	Sell	51 days May 11, 2026 → Jul 1, 2026	≥$15K
Ro Khanna D · HOUSE · CA-17	Sell	25 days May 15, 2026 → Jun 9, 2026	≥$1K
Ro Khanna D · HOUSE · CA-17	Buy	8 days Mar 30, 2026 → Apr 7, 2026	≥$1K
Michael T. McCaul R · HOUSE · TX-10	Sell	33 days Jan 9, 2026 → Feb 11, 2026	≥$15K
Ro Khanna D · HOUSE · CA-17	Buy	8 days Jan 29, 2026 → Feb 6, 2026	≥$1K
Michael T. McCaul R · HOUSE · TX-10	Sell	21 days Aug 21, 2025 → Sep 11, 2025	≥$1K
Julie Johnson D · HOUSE · TX-32	Sell	43 days Apr 1, 2025 → May 14, 2025	≥$1K
Ro Khanna D · HOUSE · CA-17	Sell	27 days Apr 15, 2025 → May 12, 2025	≥$1K
Robert Bresnahan R · HOUSE · PA-8	Buy	30 days Apr 8, 2025 → May 8, 2025	≥$1K

Congressional trading data provided by QuiverQuant

Institutional

Investors holding

575

13F shares

123.9M

Total invested

$10.3B

Ownership

109.2%

New positions

Closed positions

Increased positions

242

Reduced positions

223

Put/Call ratio

0.39

Holder	Reported	Shares	Value	Δ Qtr
KOHLBERG KRAVIS ROBERTS & CO. L.P.	8/14/2026	15.7M	$1.3B	+0.00%
FMR LLC	8/13/2026	7.6M	$630.9M	+32.01%
BLACKROCK, INC.	8/7/2026	7M	$586.7M	+0.02%
ARTISAN PARTNERS LIMITED PARTNERSHIP	8/13/2026	6.5M	$540.2M	−1.61%
VANGUARD CAPITAL MANAGEMENT LLC	8/13/2026	6.3M	$530.1M	−1.19%
JPMORGAN CHASE & CO	8/12/2026	4.3M	$366.4M	−4.81%
STATE STREET CORP	9/22/2026	4.3M	$359.6M	−1.68%
VANGUARD PORTFOLIO MANAGEMENT LLC	8/13/2026	4.1M	$345.2M	−1.47%
AMERICAN CENTURY COMPANIES INC	8/12/2026	3.5M	$288.7M	−3.82%
DIMENSIONAL FUND ADVISORS LP	8/11/2026	3.4M	$283.5M	+18.14%
SOUTHPOINT CAPITAL ADVISORS LP	8/14/2026	3.3M	$275.6M	+3.12%
INVESCO LTD.	8/14/2026	3.2M	$263.1M	−35.53%
CITADEL ADVISORS LLC	9/2/2026	2.9M	$244.0M	+8703.01%
GEODE CAPITAL MANAGEMENT, LLC	8/12/2026	2.7M	$227.5M	−1.49%
PALESTRA CAPITAL MANAGEMENT LLC	8/14/2026	2.4M	$204.3M	−28.31%
BANK OF MONTREAL /CAN/	8/12/2026	2.1M	$176.7M	+3.50%
MORGAN STANLEY	8/13/2026	2.1M	$175.5M	+47.25%
FIDUCIARY MANAGEMENT INC /WI/	8/13/2026	1.8M	$151.8M	−7.00%
LYRICAL ASSET MANAGEMENT LP	8/12/2026	1.5M	$122.6M	−4.99%
UBS GROUP AG	8/13/2026	1.3M	$111.7M	+26.66%
SWEDBANK AB	7/15/2026	1.3M	$109.5M	+0.00%
M.D. SASS, INC.	8/7/2026	1.3M	$107.5M	+1.07%
SNYDER CAPITAL MANAGEMENT L P	8/13/2026	1.3M	$107.3M	+1.29%
SCHRODER INVESTMENT MANAGEMENT GROUP	8/13/2026	1.3M	$107.3M	−15.97%
NORGES BANK	8/12/2026	1.2M	$103.4M	—

Insider transactions

Insider	Type	Transacted	Price	Date
Albertini Andrea	D-RETURN	4K	—	Sep 8
Albertini Andrea	F-INKIND	603	$88.86	Sep 8

Analyst consensus

Buy34 analysts

Bearish · 3 · Hold · 14 · Bullish · 17

Earnings history

	EPS	Estimate
Q3 2024	$1.22	$1.16	Beat
Q4 2024	$1.19	$1.23	Miss
Q1 2025	$1.15	$1.11	Beat
Q2 2025	$1.10	$1.18	Miss
Q3 2025	$1.38	$1.27	Beat
Q4 2025	$1.34	$1.30	Beat
Q1 2026	$1.32	$1.20	Beat
Q2 2026	$1.27	$1.24	Beat

Peers

Company overview

IPO dateNov 3, 1995

CEOFrederick Lowery

Employees25,000

SectorHealthcare

IndustryMedical - Distribution

CountryUS

ExchangeNASDAQ Global Select

Websitewww.henryschein.com

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.